Peixoto de Miranda Érique José F, Bittencourt Márcio Sommer, Santos Itamar S, Lotufo Paulo A, Benseñor Isabela M
Centro de Pesquisa Clínica, Hospital Universitário, Universidade de São Paulo, São Paulo, Brazil.
Eur Thyroid J. 2016 Dec;5(4):240-246. doi: 10.1159/000448683. Epub 2016 Sep 2.
Subclinical hypothyroidism (SCH) is associated with an increased cardiovascular risk, but little information is available about its association with high-sensitivity C-reactive protein (hs-CRP).
This study aims to analyze the association between SCH and hs-CRP using baseline data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
The study has a cross-sectional design. We included subjects with normal thyroid function (thyroid-stimulating hormone, TSH, 0.4-4.0 μIU/ml and normal free thyroxine, fT, 10.3-24.45 pmol/l) and SCH (TSH >4.0 μIU/ml and normal fT) who were evaluated for hs-CRP. We excluded individuals on medications that affect thyroid function and those who had prevalent cardiovascular disease. Multivariate linear regression evaluated hs-CRP and TSH as continuous variables, and logistic regression models assessed hs-CRP ≥19.05 nmol/l as the dependent variable and crescent quintiles of TSH as the independent variables adjusted for demographic and cardiovascular risk factors.
We included 12,284 subjects with a median age of 50 years (interquartile range = 45-57); 6,408 (52.2%) were female, 11,589 (94.3%) were euthyroid, and 695 (5.7%) had SCH. Bivariate analyses of participants stratified into quintiles of TSH revealed differences according to hs-CRP but not the Framingham risk score. The fifth quintile of TSH was not associated with elevated hs-CRP, odds ratio = 1.11 (95% confidence interval = 0.98-1.26), p = 0.102, in a fully adjusted logistic model, also consistent with the linear model (β = 0.024, p = 0.145).
TSH is not associated with hs-CRP. Obesity and insulin resistance are very important confounders in the study of the association between SCH and hs-CRP.
亚临床甲状腺功能减退(SCH)与心血管疾病风险增加相关,但关于其与高敏C反应蛋白(hs-CRP)之间关联的信息较少。
本研究旨在利用巴西成人健康纵向研究(ELSA-Brasil)的基线数据,分析SCH与hs-CRP之间的关联。
本研究采用横断面设计。我们纳入了甲状腺功能正常(促甲状腺激素,TSH,0.4 - 4.0 μIU/ml且游离甲状腺素,fT,正常,10.3 - 24.45 pmol/l)以及SCH(TSH > 4.0 μIU/ml且fT正常)的受试者,并对其进行hs-CRP评估。我们排除了正在服用影响甲状腺功能药物的个体以及患有心血管疾病的个体。多变量线性回归将hs-CRP和TSH作为连续变量进行评估,逻辑回归模型将hs-CRP≥19.05 nmol/l作为因变量,将TSH的递增五分位数作为自变量,并对人口统计学和心血管危险因素进行了校正。
我们纳入了12284名受试者,中位年龄为50岁(四分位间距 = 45 - 57);6408名(52.2%)为女性,11589名(94.3%)甲状腺功能正常,695名(5.7%)患有SCH。对按TSH五分位数分层的参与者进行的双变量分析显示,根据hs-CRP存在差异,但根据弗雷明汉风险评分无差异。在完全校正的逻辑模型中,TSH的第五五分位数与hs-CRP升高无关,比值比 = 1.11(95%置信区间 = 0.98 - 1.26),p = 0.102,这也与线性模型一致(β = 0.024,p = 0.145)。
TSH与hs-CRP无关。肥胖和胰岛素抵抗在SCH与hs-CRP关联研究中是非常重要的混杂因素。